These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 27826123)
1. Novel strategies of adoptive immunotherapy: How natural killer cells may change the treatment of elderly patients with acute myeloblastic leukemia. Lemoli RM; Parisi S; Curti A Exp Hematol; 2017 Jan; 45():10-16. PubMed ID: 27826123 [TBL] [Abstract][Full Text] [Related]
2. Clinical Relevance of Apheretic Graft Composition in Patients With Acute Myeloblastic Leukemia Who Received a Busulfan-Fludarabine-Antithymocyte Globulin Conditioning Regimen for Allogeneic Transplant. Yeral M; Kasar M; Boga C; Kozanoglu I; Ozdogu H; Sariturk C Exp Clin Transplant; 2015 Oct; 13(5):453-60. PubMed ID: 26103468 [TBL] [Abstract][Full Text] [Related]
3. Adoptive cell therapy for acute myeloid leukemia. Ma H; Padmanabhan Iyer S; Parmar S; Gong Y Leuk Lymphoma; 2019 Jun; 60(6):1370-1380. PubMed ID: 30628504 [TBL] [Abstract][Full Text] [Related]
4. Natural Killer Cell-Based Immunotherapy in Acute Myeloid Leukemia: Lessons for the Future. Muntasell A; López-Botet M Clin Cancer Res; 2016 Apr; 22(8):1831-3. PubMed ID: 26903071 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in acute myeloid leukemia. Arpinati M; Curti A Immunotherapy; 2014; 6(1):95-106. PubMed ID: 24341888 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy with natural killer cells: a possible approach for the treatment of Acute Myeloid Leukemia also in Brazil. Silla L Rev Assoc Med Bras (1992); 2016 Oct; 62 Suppl 1():23-24. PubMed ID: 27982314 [TBL] [Abstract][Full Text] [Related]
19. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects. Guo H; Qian X Onkologie; 2010; 33(7):389-95. PubMed ID: 20631487 [TBL] [Abstract][Full Text] [Related]